Independence Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Independence Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$139K	Hold	1,300	–	–	0.03%	105
2020 Q2	$197K	Hold	1,300	–	–	0.05%	98
2020 Q1	$108K	Hold	1,300	–	–	0.03%	90
2019 Q4	$220K	Hold	1,300	–	–	0.05%	92
2019 Q3	$241K	Hold	1,300	–	–	0.06%	85
2019 Q2	$297K	Hold	1,300	–	–	0.08%	71
2019 Q1	$273K	Hold	1,300	–	–	0.08%	72
2018 Q4	$150K	Hold	1,300	–	–	0.05%	84
2018 Q3	$298K	Hold	1,300	–	–	0.09%	61
2018 Q2	$290K	Hold	1,300	–	–	0.09%	60
2018 Q1	$297K	Hold	1,300	–	–	0.1%	60
2017 Q4	$341K	Hold	1,300	–	–	0.12%	54
2017 Q3	$292K	Hold	1,300	–	–	0.12%	53
2017 Q2	$356K	Hold	1,300	–	–	0.14%	48
2017 Q1	$315K	Hold	1,300	–	–	0.13%	52
2016 Q4	$270K	Hold	1,300	–	–	0.12%	55
2016 Q3	$354K	Buy	+1,300	New	+$288K	0.17%	46

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Independence Advisors's AXDX Position: Q3 2020 in Review

Independence Advisors held its Accelerate Diagnostics (AXDX) position steady in Q3 2020 at 1,300 shares worth $139K. The position accounts for 0.03% of the portfolio, ranked #105.

Independence Advisors first reported a position in AXDX in Q3 2016 and has held it in 17 quarters since. The position peaked at $356K in Q2 2017. 112 funds tracked by Wall St. Rank hold AXDX as of Q3 2020.

Independence Advisors held 1,300 shares of Accelerate Diagnostics worth $139K as of Q3 2020.
Independence Advisors left its Accelerate Diagnostics share count unchanged in Q3 2020.
Accelerate Diagnostics made up 0.03% of Independence Advisors's portfolio in Q3 2020, its #105 holding.
Independence Advisors first reported a position in Accelerate Diagnostics in Q3 2016 and has held it in 17 quarters since.
Independence Advisors's Accelerate Diagnostics position peaked at $356K in Q2 2017.
112 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2020.

Based on Independence Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.